These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 33052245
1. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury. Chen G, Xu C, Gillette TG, Huang T, Huang P, Li Q, Li X, Li Q, Ning Y, Tang R, Huang C, Xiong Y, Tian X, Xu J, Xu J, Chang L, Wei C, Jin C, Hill JA, Yang Y. Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245 [Abstract] [Full Text] [Related]
3. Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo. Li Q, Cui HH, Yang YJ, Li XD, Chen GH, Tian XQ, Jin C, Dong QT, Huang PS, Xu J. Cell Physiol Biochem; 2017; 41(4):1503-1518. PubMed ID: 28334711 [Abstract] [Full Text] [Related]
7. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Chen Y, Ba L, Huang W, Liu Y, Pan H, Mingyao E, Shi P, Wang Y, Li S, Qi H, Sun H, Cao Y. Eur J Pharmacol; 2017 Feb 05; 796():90-100. PubMed ID: 27916558 [Abstract] [Full Text] [Related]
8. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. Riquelme JA, Westermeier F, Hall AR, Vicencio JM, Pedrozo Z, Ibacache M, Fuenzalida B, Sobrevia L, Davidson SM, Yellon DM, Sánchez G, Lavandero S. Pharmacol Res; 2016 Jan 05; 103():318-27. PubMed ID: 26607864 [Abstract] [Full Text] [Related]
12. Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1. Chen GH, Xu CS, Zhang J, Li Q, Cui HH, Li XD, Chang LP, Tang RJ, Xu JY, Tian XQ, Huang PS, Xu J, Jin C, Yang YJ. Front Pharmacol; 2017 Jan 05; 8():775. PubMed ID: 29163161 [Abstract] [Full Text] [Related]
14. Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury. Qi K, Li L, Li X, Zhao J, Wang Y, You S, Hu F, Zhang H, Cheng Y, Kang S, Cui H, Duan L, Jin C, Zheng Q, Yang Y. PLoS One; 2015 Jan 05; 10(3):e0119846. PubMed ID: 25781461 [Abstract] [Full Text] [Related]
15. Induction of cardioprotection by small netrin-1-derived peptides. Li Q, Cai H. Am J Physiol Cell Physiol; 2015 Jul 15; 309(2):C100-6. PubMed ID: 25924621 [Abstract] [Full Text] [Related]
16. Key role of endothelium in the eNOS-dependent cardioprotection with exercise training. Farah C, Nascimento A, Bolea G, Meyer G, Gayrard S, Lacampagne A, Cazorla O, Reboul C. J Mol Cell Cardiol; 2017 Jan 15; 102():26-30. PubMed ID: 27866931 [Abstract] [Full Text] [Related]
17. Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells. Qi K, Yang Y, Geng Y, Cui H, Li X, Jin C, Chen G, Tian X, Meng X. Medicine (Baltimore); 2020 Aug 21; 99(34):e21821. PubMed ID: 32846824 [Abstract] [Full Text] [Related]
19. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjöquist PO, Pernow J. Am J Physiol Heart Circ Physiol; 2009 Mar 21; 296(3):H719-27. PubMed ID: 19151258 [Abstract] [Full Text] [Related]